Harrison.ai creates AI-powered diagnostic tools for radiology and pathology to help healthcare providers diagnose and treat patients more efficiently. The software analyzes medical data at scale, enabling doctors to review images and test results faster and with fewer delays. It partners with clinicians to develop these AI solutions and then licenses or sells them to hospitals and other healthcare providers to integrate into care workflows. What sets Harrison.ai apart is its focus on two high-demand diagnostic fields—radiology and pathology—and its collaboration with medical specialists to tailor AI tools to real clinical needs, aiming to fit into existing hospital systems. The company’s goal is to scale global healthcare capacity and raise the standard of care for millions of patients by expanding access to accurate, timely diagnoses.
Company Size
51-200
Company Stage
Series C
Total Funding
$217.6M
Headquarters
Sydney, Australia
Founded
2018
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?